广发中证香港创新药(QDII-ETF)(513120)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
8,488,640,000 |
9,113,640,000 |
1,603,000,000 |
978,000,000 |
625,000,000 |
7.36% |
2023/12/31 |
187,635,000 |
8,488,640,000 |
9,447,500,000 |
1,146,500,000 |
8,301,000,000 |
4424.01% |
2023/12/31 |
5,143,140,000 |
8,488,640,000 |
3,926,500,000 |
581,000,000 |
3,345,500,000 |
65.05% |
2023/9/30 |
3,134,640,000 |
5,143,140,000 |
2,525,000,000 |
516,500,000 |
2,008,500,000 |
64.07% |
2023/6/30 |
187,635,000 |
3,134,640,000 |
2,996,000,000 |
49,000,000 |
2,947,000,000 |
1570.6% |
2023/6/30 |
584,635,000 |
3,134,640,000 |
2,586,000,000 |
36,000,000 |
2,550,000,000 |
436.17% |
2023/3/31 |
187,635,000 |
584,635,000 |
410,000,000 |
13,000,000 |
397,000,000 |
211.58% |
2022/12/31 |
300,135,000 |
187,635,000 |
88,500,000 |
201,000,000 |
-112,500,000 |
-37.48% |
2022/12/31 |
146,635,000 |
187,635,000 |
47,000,000 |
6,000,000 |
41,000,000 |
27.96% |
2022/9/30 |
300,135,000 |
146,635,000 |
41,500,000 |
195,000,000 |
-153,500,000 |
-51.14% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。